Lyndhurst, NJ, April 26, 2018 - Scarinci Hollenbeck is proud to announce that Partner and Co-Chair of the firm’s Corporate Transactions & Business practice group, Donald M. Pepe, has been recognized by the New Jersey Law Journal as one of 2018’s Dealmakers of the Year. The Journal sought to “recognize excellence in Corporate, M&A, Real Estate, Bankruptcy and other transactional practices in the Garden State.” Mr. Pepe was one of just two practitioners to receive the individual Dealmaker of the Year award.
Mr. Pepe is being recognized for his work in various real estate development projects in New Jersey. A project that stood out was Hoboken Brownstone’s Coles Street development. This is a major redevelopment project being conducted in Jersey City, which was inhibited by financial obstacles. Without Mr. Pepe’s unique approach in banding together four other developers to establish a special improvement district plan, the project would not have been able to move forward. This is just one example of several successful projects in which Mr. Pepe has had direct involvement.
“It’s an honor to be recognized by the NJ Law Journal. The last few years of my professional career have been very exciting and this recognition only makes it that much more enjoyable, ” said Mr. Pepe.
The winners will be profiled in the New Jersey Law Journal’s upcoming Professional Excellence magazines and honored June 21, 2018 at the Professional Excellence Event at Brookdale Country Club in Florham Park, NJ.
For more information on the event, please click here.
Donald M. Pepe devotes his practice to all aspects of complex real estate development and real estate transactional work with an emphasis on retail and residential development. Mr. Pepe works closely with business executives and in-house counsel to develop strategies for targeting acquisitions, land purchase negotiations, managing and evaluating feasibility studies, representing corporate interests before local, state and federal approval authorities, and securing land use and administrative approvals.